Cash from Operations (Quarterly) Chart

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 -0.887M
March 31, 2026 -1.142M
December 31, 2025 -1.147M
September 30, 2025 -3.528M
June 30, 2025 -2.282M
March 31, 2025 -1.598M
December 31, 2024 -0.845M
September 30, 2024 -0.449M
June 30, 2024 -1.166M
March 31, 2024 -0.45M
December 31, 2023 -0.816M
September 30, 2023 -1.412M
June 30, 2023 -4.811M
March 31, 2023 -3.318M
December 31, 2022 -7.276M
September 30, 2022 -6.548M
June 30, 2022 -9.078M
March 31, 2022 -13.26M
Date Value
December 31, 2021 -13.80M
September 30, 2021 4.863M
June 30, 2021 -11.08M
March 31, 2021 -14.81M
December 31, 2020 -11.81M
September 30, 2020 -8.549M
June 30, 2020 -11.07M
March 31, 2020 -7.847M
December 31, 2019 15.33M
September 30, 2019 -4.965M
June 30, 2019 -5.036M
March 31, 2019 -4.012M
December 31, 2018 -5.963M
September 30, 2018 -4.193M
June 30, 2018 -4.684M
March 31, 2018 -4.647M
December 31, 2017 -5.342M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Tenax Therapeutics, Inc. -14.15M
Century Therapeutics, Inc. -19.83M
Absci Corp. -27.56M
Celularity, Inc. 1.447M
Cardio Diagnostics Holdings, Inc. -1.342M

Cash from Operations (Quarterly) Related Metrics